Journal List > Korean J Pediatr Infect Dis > v.20(3) > 1096035

Kim: Reemerging Old Infectious Diseases: Diagnosis of Measles, Mumps, Rubella, and Pertussis

Abstract

Reemerging infectious diseases are infections that had decreased in incidence in the global population and were brought under control through effective health care policy such as vaccination, but more recently, began to resurge as a health problem due to many reasons. Measles, rubella, mumps and pertussis are the examples. Immunization with MMR (measles, mumps, rubella) and pertussis vaccine has contributed to marked decrease in measles, mumps, rubella and pertussis incidence worldwide. In Korea, measles and rubella almost disappeared after the introduction of 2 doses of MMR immunization schedule. Recently, these infections have been reemerging in many countries with low vaccination rates and can be introduced again in Korea. However mumps and pertussis outbreaks are reported among fully vaccinated populations. Declining vaccine effectiveness, an increased awareness and surveillance of the disease or improved laboratory diagnostic tools had been suggested as possible causes. For the clinicians, it is difficult to diagnose these reemerging infectious diseases partly because of few experience of typical cases of measles and rubella or partly because of modification of clinical symptoms and signs of infectious diseases in immunized population. In this article, the diagnosis of measles, mumps, rubella and pertussis will be reviewed in the aspects of clinical characteristics, serologic methods, virus isolation, and polymerase chain reaction.

Figures and Tables

Table 1
Measles Case Definition of National Notifiable Diseases Surveillance System, CDC, US in 2013
kjpid-20-115-i001

*Temperature does not need to reach ≥101°F/38.3℃ and rash does not need to last ≥3 days.

Not explained by MMR vaccination during the previous 6-45 days.

Not otherwise ruled out by other confirmatory testing or more specific measles testing in a public health laboratory

Table 2
Rubella Case Definition of National Notifiable Diseases Surveillance System, CDC, US in 2013
kjpid-20-115-i002

*Not explained by MMR vaccination during the previous 6-45 days.

Not otherwise ruled out by more specific testing in a public health lab.

Table 3
Mumps Case Definition of National Notifiable Diseases Surveillance System, CDC, US in 2012
kjpid-20-115-i003
Table 4
Pertussis Case Definition of National Notifiable Diseases Surveillance System, CDC, US in 2010
kjpid-20-115-i004

References

1. Asaria P, MacMahon E. Measles in the United Kingdom: can we eradicate it by 2010? BMJ. 2006; 333:890–895.
crossref
2. Centers for Disease Control and Prevention. Nationwide Rubella Epidemic - Japan, 2013. MMWR Morb Mortal Wkly Rep. 2013; 62:457–462.
3. Kutsuna S, Hayakawa K. Images in clinical medicine. Rubella rash. N Engl J Med. 2013; 369:558.
4. Centers for Disease Control and Prevention. Update: mumps outbreak-New York and New Jersey, June 2009-January 2010. MMWR Morb Mortal Wkly Rep. 2010; 59:125–128.
5. Centers for Disease Control and Prevention. Mumps epidemic-United Kingdom, 2004-2005. MMWR Morb Mortal Wkly Rep. 2006; 55:173–178.
6. Centers for Disease Control and Prevention. Mumps epidemic-Iowa, 2006. MMWR Morb Mortal Wkly Rep. 2006; 55:366–368.
7. Centers for Disease Control and Prevention. Update: multistate outbreak of mumps-United States, January 1-May 2, 2006. MMWR Morb Mortal Wkly Rep. 2006; 55:559–564.
8. Centers for Disease Control and Prevention. Use of mass Tdap vaccination to control an outbreak of pertussis in a high school-Cook County, Illinois, September 2006-January 2007. MMWR Morb Mortal Wkly Rep. 2008; 57:796–799.
9. Centers for Disease Control and Prevention. Local health department costs associated with response to a school-based pertussis outbreak-Omaha, Nebraska, Sept-Nov,2008. MMWR Morb Mortal Wkly Rep. 2011; 60:5–8.
10. Mason WH. Measles. In : Kliegman RM, editor. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Elsevier Saunders;2011. p. 1069–1075.
11. Cherry JD. Measles virus. In : Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL, editors. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 6th ed. Philadelphia: Elsevier Saunders;2009. p. 2427–2450.
12. American Academy of Pediatrics. Measles. In : Pickering LK, Baker CJ, Kimberlin DW, Long SS, editors. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics;2012. p. 489–499.
13. The Korean Pediatric Society. Measles, mumps rubella vaccine. In : Lee HJ, editor. Immunization Guideline. 7th ed. Seoul: The Korean Pediatric Society;2012. p. 92–108.
14. Centers for Disease Control and Prevention. Elimination of Measles-South Korea, 2001-2006. MMWR Morb Mortal Wkly Rep. 2007; 56:304–307.
15. Korea Centers for Disease Control and Prevention. Results and lessons from the catch-up MR vaccination campaigns for the elimination of 2000-2001 measles outbreak in Korea. Commun Dis Monthly Rep, Korea. 2002; 13:19–24.
16. Korea Centers for Disease Control and Prevention. Recent trends in notifiable diseases occurrence based on the data of 2004. Commun Dis Monthly Rep, Korea. 2005; 16:121–131.
17. Kutty P, Rota J, Bellini W, Redd SB, Barskey A, Wallacel G. Measles. Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. 6th ed. Atlanta, GA: Centers for Disease Control and Prevention;2013. chapter 7-1-21.
18. McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS. Centers for Disease Control and Prevention. Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013, Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013; 62(RR-04):1–34.
19. Mason WH. Rubella. In : Kliegman RM, editor. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Elsevier Saunders;2011. p. 1075–1078.
20. Cherry JD. Rubella virus. In : Feigin RD, editor. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 6th ed. Philadelphia: Elsevier Saunders;2009. p. 2271–2300.
21. American Academy of Pediatrics. Rubella. In : Pickering LK, Baker CJ, Kimberlin DW, Long SS, editors. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics;2012. p. 629–632.
22. McLean H, Redd S, Abernathy E, Icenogle J, Wallacel G. Rubella. Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. 6th ed. Atlanta, GA: Centers for Disease Control and Prevention;2013. chapter 14-1-11.
23. Mason WH. Mumps. In : Kliegman RM, editor. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Elsevier Saunders;2011. p. 1078–1081.
24. Cherry JD. Mumps virus. In : Feigin RD, editor. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 6th ed. Philadelphia: Elsevier Saunders;2009. p. 2451–2461.
25. American Academy of Pediatrics. Mumps. In : Pickering LK, Baker CJ, Kimberlin DW, Long SS, editors. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics;2012. p. 514–518.
26. Amy Parker Fiebelkorn AP, Barskey A, Hickman C, Bellini W. Mumps. Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. 6th ed. Atlanta, GA: Centers for Disease Control and Prevention;2013. chapter 9-1-17.
27. Domínguez A, Torner N, Castilla J, Batalla J, Godoy P, Guevara M, et al. Mumps vaccine effectiveness in highly immunized populations. Vaccine. 2010; 28:3567–3570.
crossref
28. Davidkin I, Jokinen S, Paananen A, Leinikki P, Peltola H. Etiology of mumps-like illnesses in children and adolescents vaccinated for mealses, mumps, and rubella. J Infect Dis. 2005; 191:719–723.
crossref
29. Long SS. Pertussis. In : Kliegman RM, editor. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Elsevier Saunders;2011. p. 944–948.
30. Cherry JD, Heininger U. Pertussis and Other Bordetella infections. In : Feigin RD, editor. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 6th ed. Philadelphia: Elsevier Saunders;2009. p. 1683–1693.
31. American Academy of Pediatrics. Pertussis. In : Pickering LK, Baker CJ, Kimberlin DW, Long SS, editors. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics;2012. p. 553–566.
32. McIntyre P, Wood N. Pertussis in early infancy: disease burden and preventive strategies. Curr Opin Infect Dis. 2009; 22:215–223.
crossref
33. Castagnini LA, Munoz FM. Clinical characteristics and outcomes of neonatal pertussis: a comparative study. J Pediatr. 2010; 156:498–500.
crossref
34. American Academy of Pediatrics. Committee on Infectious Diseases. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics. 2006; 117:965–978.
35. Cornia PB, Hersh AL, Lipsky BA, Newman TB, Gonzales R. Does this coughing adolescent or adult patient have pertussis? JAMA. 2010; 304:890–896.
crossref
36. Halperin SA. The control of pertussis-2007 and beyond. N Engl J Med. 2007; 356:110–113.
37. Mooi FR, van Loo IH, van Gent M, He Q, Bart MJ, Heuvelman KJ, et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis. 2009; 15:1206–1213.
crossref
38. The Korean Pediatric Society. DTaP, Tdap, Td vaccine. In : Lee HJ, editor. Immunization Guideline. 7th ed. Seoul: The Korean Pediatric Society;2012. p. 92–108.
39. Faulkner A, Skoff T, Martin S, Cassiday P, Tondella ML, Liang J, et al. Pertussis. Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. 6th ed. Atlanta, GA: Centers for Disease Control and Prevention;2013. chapter 10-1-12.
TOOLS
Similar articles